Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Its early data is remarkable, with up to 24% weight loss at 36 weeks subcutaneously and 13.1% at 12 weeks orally
Summary: Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) showing promising liver fat reduction in Phase 2 trials, but it does not yet hold UK marketing authorisation
The treatment benefit for heart failure with preserved ejection fraction, accounting for more than half of heart failure cases, has now been replicated
Discussion should cover injection technique, adverse effect management, cost considerations (often $900-1,300 monthly without insurance coverage), and long-term treatment duration, as weight regain commonly occurs after discontinuation
(The post featured a noticeably slimmed down Musk dressed in traditional Santa attire.) Tech moguls and celebrities aside, Healthline reports that an estimated 13% of all Americans have now tried Ozempic or a similar-acting drug, such as Mounjaro (which is the drug Musk admittedly used for his own weight loss)
